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Abstract
Objective: Because partners are an important and unpaid resource in cancer care, understanding how
destructive, controlling or interfering partner behaviors influence women’s cancer care may be partic-
ularly relevant for health care providers seeking to provide cancer care and enhance recovery. Using a
new measure of partner interfering behaviors in cancer care (PIB-C), we investigated whether women
with a recent cancer diagnosis who additionally endorsed any PIB-C would report (a) more symptoms
of depression and stress, and (b) lower Functional Assessment of Cancer Therapy (FACT-G) and
lower Functional Assessment of Chronic Illness Therapy-Spiritual Well-being (FACIT-SP) scale scores
indicating poorer quality of life (QOL).
Methods: Women aged 18–79 included in cancer registries as having an incident, primary, biopsy-
confirmed cancer in the past 12 months were eligible for this study. Consenting women completed a
phone interview 9–12 months following cancer diagnosis between 2009 and 2015. Interviews provided
data to measure outcomes (perceived stress and depressive symptoms, FACIT-SP and FACT-G
scores), partner supportive and interfering behaviors, and other potentially confounding factors.
Results: Of the 2376 women in a relationship at cancer diagnosis, 14.7% endorsed one or more of 14
PIB-C items. Women endorsing any PIB-C item reported more symptoms of depression and stress and
lower FACT-G and FACIT-SP scores than partnered women reporting no PIB-C even when control-
ling for partner supportive behaviors and lifetime intimate partner violence. Increasing PIB-C scores
were also correlated, in a dose–response pattern, with these same outcomes.
Conclusions: Partner interfering behaviors during cancer care impact patients’ QOL across multi-
ple domains.
© 2016 The Authors. Psycho-Oncology Published by John Wiley & Sons Ltd.
Introduction
Intimate partner violence (IPV) has been associated with in-
creased symptoms of depression, anxiety and poorer func-
tioning for women undergoing cancer therapy following
diagnosis [1]. This relationship held for women experienc-
ing IPV in a current or past relationship and for those
experiencing sexual, physical or psychological IPV relative
to those never experiencing IPV. That study found that cur-
rent psychological IPV was most strongly associated with
poorer quality of life (QOL) scores [1]. A recent qualitative
study of 21 partnered women experiencing both violence
and cancer reported that partners’ abusive behaviors in-
creased during treatment and, these physical, sexual or psy-
chologically abusive behaviors contributed to delays in
[cancer] treatment [2]. Four themes emerged from this qual-
itative research regarding partners’ actions toward women
during their cancer care: (a) self-centered focus, (b) contin-
ued expectations of cancer patient despite receiving cancer
treatment, (c) critical, demanding or ‘mean’ behaviors and
(d) withdrawal of affection. These data suggest that abusive
behaviors by a current partner may specifically impact pa-
tients’ ability to psychologically recover and adjust follow-
ing both diagnosis of and treatment for cancer.
Mechanistically, how might abusive or specifically
interfering partner behaviors influence treatment or re-
covery among those diagnosed with cancer? Convinc-
ing evidence now links chronic stress, depression and
cancer progression [3–5]. Stressed individuals are more
likely to smoke, excessively consume alcohol and be-
come obese; all three stress responses are associated
with chronic inflammation which may influence cancer
risk or progression [3]. Thai researchers have recently
observed that partner violence had direct effects on
lower social support, increased stress, depressive symp-
toms and cervical cancer (p< .01) among 532 women
and stress alone mediated the effect of partner violence
on cancer. [6] While stress may not cause cancer, stress
does influence this disease’s process [3,4]. Partner vio-
lence has consistently been associated with increased
self-perceived stress including symptoms of post-
traumatic stress disorder (PTSD) among women with
[1] and without cancer [7,8]. Both the well-documented
association between partner violence and PTSD as well
as meta-analyses documenting stress and depression [9]
as important factors in cancer progression provide addi-
tional impetus to determine the impact of negative part-
ner behaviors during cancer care and recovery. Partner
© 2016 The Authors. Psycho-Oncology Published by John Wiley & Sons Ltd.
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interfering behaviors may directly affect cancer care by
delaying or sabotaging treatment or recovery plans and
impact prognosis through increasing patient stress.
The role of patients’ social support has been explored as
a potential buffer for the inevitable stress associated with a
cancer diagnosis and its treatment. Social support has been
found to improve post-treatment physical functioning for
cancer patients when measured using validated quality of
life measures [10–12]. Intimate partners appear to be the
more significant member of patients’ social networks in
terms of providing needed support [13]. While intimate
partners may be crucial members of women’s social
networks [11,12], partner interactions may be both sup-
portive and unsupportive or directly aversive [14,15], yet
with the exception of the work by Manne & Schnoll,
few have measured unsupportive or interfering partner
behaviors that may impact cancer care.
Manne and Schnoll developed the Partner Responses to
Cancer Inventory (PRCI) as a measure of both positive
and negative spouse responses to patients with cancer.
This 45-item measure had four loading factors; two mea-
sured unsupportive partner behaviors characterized as crit-
icism or withdrawal and distancing or self-restraint [16].
Investigators have further used the partner unsupportive
behaviors measure to determine adaptation in early stage
breast cancer patients (n=330) and their spouses.
Unsupportive partner behaviors were found to positively
correlate with patients’ increased cancer distress and were
mediated by mental and behavioral disengagement [17].
The current study builds on prior research which noted
that partner abusive or violent behaviors [1] as well as
unsupportive behaviors [17] influence patients’ percep-
tions of their own distress and poorer quality of life. We
have chosen to examine specific interfering or controlling
behaviors by a partner which may influence a cancer pa-
tient’s perceived quality of life or indirectly impact receipt
of cancer care. Our new measures of partner interfering
behaviors in cancer care coupled with a concurrent mea-
sure of partner supportive behaviors (PIB-C and PSB-C)
were found to have strong psychometric properties [18].
Subscales from factor analysis of the PIB-C revealed
themes consistent with qualitative reports from abused
women cancer patients: partner focused on self, not
patient; partner undermining the seriousness of her cancer,
and partner’s interference in her cancer care. This scale
appears to provide a reliable measure of partner interfering
behaviors which may impact cancer care and psychologi-
cal adaption following cancer diagnosis and treatment.
The aim of this research was to determine whether, and
if so how, partner interfering behaviors in cancer care
(PIB-C) were associated with distress and quality of life
measures among women recently diagnosed with cancer.
We hypothesized that higher PIB-C scores would be asso-
ciated with (a) more symptoms of depression or stress, and
(b) lower cancer-related quality of life as measured by
FACT-G scores. Because partner support has been associ-
ated with superior cancer outcomes [19], analyses were
adjusted for partner support, lifetime IPV and other rele-
vant demographic and stage at cancer diagnosis and num-
ber of comorbid physical conditions at cancer diagnosis.
Both supportive and aversive behaviors may occur within
the same member and may be more harmful than aversive
behaviors alone [20].
Method
Participant recruitment
Women included in the Kentucky Cancer Registry
(KCR) or the North Carolina Central Cancer Registry
(NCCR) Rapid Case Ascertainment program as an
incident and primary case of cancer were eligible for this
study. Recruitment from both state registries was needed
to yield the target study size; case recruitment began
with KCR in November 2009 through December 2013
and in October 2013 case recruitment began at NCCR
with recruitment through January 2015. Only women
ages 18–79 at cancer diagnosis who were additionally
diagnosed and included in the state registry in the prior
12 months were eligible. Those with a recurrent cancer,
a squamous cell skin carcinoma, non-residents of either
Kentucky or North Carolina and those unable or willing
to provide consent were not eligible for study
participation.
The registries allowed slightly different approaches to
subject contact. The primary difference was that staff at
the Kentucky Registry directly contacted eligible women
by mail (with follow up by phone if they did not respond
by mail). This direct contact by KCR staff meets with
active consent requirements of patients for researchers
contact. Contact information for consenting patients was
then forwarded to researchers for further explanation of
the protocol, opportunity to address questions and partici-
pate, if interested. In contrast with KCR, North Carolina
Registry staff allowed researchers to directly contact eligi-
ble participants. In both registries, physicians were
informed that their patients were eligible for this study
and were asked if there were any reason why a patient
should not be approached (i.e. dementia, death or being
too ill to participate). Patients, whose physicians indicated
a reason for not contacting, were not contacted.
A letter inviting participation and explaining the study
goals was sent to eligible women. This letter additionally
provided researcher contact information (name and phone
number) on an enclosed card stamped and addressed to
research staff if women wished to be interviewed or learn
more about this study. Women could also indicate that
they did not wish further contact on the same card.
Trained research staff at the University of Kentucky Sur-
vey Research Center (SRC) called eligible women to
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explain the study and answer any questions. The inter-
viewer presented a formal introduction about the study
and obtained explicit verbal consent before beginning
the interview. Phone interviews were conducted within
one year of cancer diagnosis. This study was approved
by the Institutional Review Board at the University of
Kentucky, protocol number 09-0685-F1V and an NIH
Certificate of Confidentiality was granted (MD-09-007).
Data was collected by telephone interview with an aver-
age duration of 30 min; those completing the interview
were offered US $10.00 incentive for their participation.
Measures
Abbreviated partner interfering behaviors in cancer
care (PIB-C)
For the current analyses, the 14 PIB-C items (see Table 1)
were summed to create a continuous score (overall and by
three distinct subscales), and endorsement of items was
used to create an ordinal (2 or more PIB-C items, 1 item,
or 0 PIB-C item endorsed) and dichotomous (any item
endorsed) variable. The 14-item PIB-C had good internal
consistency (Cronbach’s α=0.913 using Likert response
options and α=0.840 for yes no responses). Similarly,
when the 12-item PSB-C was reduced to 5 items for these
analyses this reduced measured continued to have good
internal consistency (Cronbach’s α=0.838).
Our abbreviated PIB-C, based on the original 20-item
measure of PIB-C, was found to have strong internal consis-
tency (Cronbach’s α=0.936) [18]. Subscales from factor
analyses revealed themes consistent with qualitative report
from abused women cancer patients [2]: partner focused
on self, not patient; partner undermining the seriousness of
her cancer, and partner’s interference in her cancer care.
The six excluded items were: Spouse or partner (a) started
more arguments than usual, (b) would not do household
chores to help with your recovery, (c) made it difficult for
you to get the physical care you needed for recovery, (d)
made you feel as though it was your fault you got cancer,
(e) reminded you how much your cancer treatment and
recovery cost the family financially and (f) let you know
how much their life was disrupted by your cancer
treatment/recovery. These items were excluded because
these were highly correlated (Pearson correlation coefficient
>0.50) with the first 14 PIB-C items and each excluded item
loaded on the three existing subscales. [Researchers may
wish to retain excluded item b because 8% of the pilot sam-
ple reported this partner behavior and this itemmost strongly
associated with the subscale, partner focusing on self].
Demographic attributes and other potentially confounding
factors were obtained directly from women or through data
available from cancer registries (see Table 2 legend for re-
sponse options andmeasure sources). Cancer registry staff pro-
vided data to describe stage at diagnosis; stage was simplify
Table 1. Partner interfering behaviors in cancer care (PIB-C): psychometric evaluation
PIB-C Items (abbreviated 14-item measure)* Agree% (n)
Factor and loadings
Partner focused on self Partner cautious Partner interfered
1. Partner interfered with your getting a doctor’s appointment 0.7 (16) 0.188 0.202 0.643
2. Partner implied you did not deserve medical treatment 0.6 (14) 0.205 0.297 0.342
3. Partner made you feel your medical needs were a burden on the family 3.3 (78) 0.724 0.166 0.144
4. Partner made you feel guilty for needing extra help or care during cancer
treatment or recovery
5.0 (118) 0.776 0.176 0.151
5. Partner refused to handle existing or new responsibilities as a result
of your cancer treatment
5.0 (120) 0.650 0.042 0.217
6. Partner created an embarrassing scene at your doctor’s office 1.1 (26) 0.125 0.356 0.649
7. Partner criticized your doctor or their medical care 2.5 (59) 0.209 0.717 0.039
8. Partner suggested that your doctor was not capable of providing medical
treatment for you
2.0 (48) 0.142 0.757 0.209
9. Partner made you think you did not have a serious medical condition 3.8 (90) 0.718 0.251 0.090
10. Partner ‘forgot’ to pick up your prescriptions. 1.7 (40) 0.186 0.186 0.676
11. Partner said no treatment until you got a second opinion. 3.1 (73) 0.098 0.653 0.045
12. Partner complained that you were not focusing on him or your family 3.9 (94) 0.696 0.112 0.185
13. Partner discouraged your talking with others about your cancers. 1.5 (36) 0.412 0.326 0.281
14. Partner did not allow to relax or recover following cancer treatment 3.4 (81) 0.679 0.186 0.120
Psychometrics of scales
# Items in factor (14 in full scale) 14 7 (Items 3-5, 9, 12-14) 3 (Items 7, 8, 11) 4 (Items 1, 2, 6, 10)
N (%) Endorsing any time in scale (or subscale) 349 (14.7) 262 (11.0) 123 (5.2) 72 (3.0)
Mean score or subscale; (range) 0.37 (0–14) 0.26 (0–7) 0.08 (0–3) 0.04 (0–4)
Cronbach’s Alpha by factor 0.840 0.835 0.651 0.560
Variance explained by factor 66.3% 19.5% 14.4%
*Agree (=1) vs disagree (=0) response options
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across all cancers stages 0–4 to range from in-situ (coded as
stage=0; and primarily breast) to evidence of metastases
(stage=4). Data to characterize the number and type of co-
morbid conditions were obtained during phone interviews;
the conditions queried included the following list of self-
report of physician-diagnosed physical conditions: high blood
pressure, heart disease, diabetes, irritable bowel syndrome, fi-
bromyalgia, stroke or liver disease. The number of comorbid
conditions was summed to create an ordinal measure.
Information to describe physical, sexual and psycholog-
ical IPV was obtained from participants. Detailed mea-
sures were described elsewhere [1]. An abbreviated form
of the Conflict Tactic Scale [21] was used to measure
physical and sexual IPV. The following three items mea-
sured physical IPV: [has any partner] (a) shoved, grabbed,
pushed, pinched, slapped, shook you or thrown non-
dangerous objects at you that was NOT done in a playful
manner? (b) hit you with a fist, kicked you, punched you,
Table 2. Demographic attributes and lifetime violence experience by partner interfering behaviors in cancer care (PIB-C)
All women with a recently diagnosed cancer
and in a relationship at diagnosis: n = 2385 Any PIB-C (n = 349) No PIB-C (n = 2036) test p value
Age at diagnosis *(Mean ± SE) 53.12 (0.58) 55.94 (0.24) t 4.53 <.0001
Number of children** (Mean ± SE) 2.09 (0.07) 2.10 (0.03) t 0.19 NS
PSB-C score ** 3.53 (.06) 4.52 (0.03) t 15.12 <.0001
χ2 df
p value
Private Insurance (vs other including uninsured)** 60.5% 64.3% 1.911
NS
Monthly income** 30.25 5
<.0001
<$1000 13.6% 6.1%
$1000–$1999 20.7% 17.7%
$2000–$2999 15.6% 17.3%
$3000–$3999 11.1% 14.3%
$4000–$4999 13.6% 16.5%
$5000+ 25.3% 28.2%
Education level** 19.53 4
<.0006
< High school (HS) degree 11.4% 6.4%
HS or graduation equivalency degree 22.7% 31.3%
Some college or associates degree 18.2% 17.4%
Bachelor degree 13.4% 14.5%
Beyond a bachelor’s degree 34.4% 30.4%
Currently married** 75.9% 87.5% 32.78 1
<.0001
Current smoker** 17.5% 10.1% 16.511
<.0001
Appalachian county of residence (%) relative to non-Appalachian* 28.1% 30.6% 0.851
NS
North Carolina resident (vs Kentucky) 25.8% 23.9% 0.61 1
NS
Diagnosed with breast cancer * 58.7% 61.1% 0.68 1
NS
Stage at cancer diagnosis 12.49 4
0.01
0 2.6% 2.2%
1 52.7% 62.6%
2 12.3% 9.9%
3 22.6% 17.4%
4 9.7% 7.9%
Number of comorbid conditions 16.38 5
.006
0 25.7% 20.8%
1 29.5% 34.9%
2 22.3% 26.0%
3 11.6% 11.9%
4 6.9% 3.9%
5 or more 4.1% 2.6%
Lifetime IPV** 69.6% 29.6% 208.311
<.0001
Sexual** 19.8% 7.8% 50.001
<.0001
Physical ** 39.3% 19.5% 66.931
<.0001
Psychological** 67.6% 26.8% 225.181
<.0001
Current IPV** 41.3% 5.4% 402.781
<.0001
Sexual** 5.0% 0.8% 29.331
<.0001
Physical ** 9.7% 1.8% 48.011
<.0001
Psychological** 40.4% 4.8% 416.121
<.0001
*Cancer Registry’s data.
**Women’s interview data.
1PSB-C (5 items; 1) partner gone with woman to doctor visits and appointments; 2) partner spend time with woman when she was in the hospital; 3) Partner was involved in
woman’s medical care; 4) Partner did something unexpected to make the woman ‘happy’; 5) Partner willingly made small sacrifices to assist in woman’s care or recovery.
2Current partner (at diagnosis) was perpetrator.
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bitten you, slapped you hard, thrown you, dragged you, hit
you with an object or used any other type of physical ag-
gression like these which could cause injuries and (c)
pointed a weapon at you, beat you up, choked you or
attempted to strangle you, burned you, used a weapon or
other dangerous object on you or used any other physical
aggression like these to hurt you? A modified version of
the Measure of Psychologically Abusive Behaviors
(MPAB) [22] in combination with the Women’s Experi-
ence with Battering Scale (WEB) [23,24] was used to mea-
sure psychological abuse. The following two grouped
items from the MPAB were used: has any partner (a)
embarrassed you in public on purpose, or yelled or
screamed, put you down, called you mean names or treated
you as an inferior, (b) used threatening behaviors toward
you or harmed or destroyed your personal things of value,
harmed pets or threatened to harm family/children or friend
to scare you. The following three items from the Women’s
Experience with Battering Scale (WEB) [23,24] were used
to measure psychological abuse: (a) Your spouse/partner
makes you feel like you have no control over your life,
no power, no protection, (b) you hide the truth about your
relationship from others because you are afraid not to and
(c) your partner can scare you without laying a hand on
you. An indicator variable of lifetime physical, sexual or
psychological IPV (ever versus never) was created.
Measures of distress and QOL outcomes
Women were recruited into the study up to 12 months af-
ter their cancer diagnosis; thus, women were asked to re-
call symptoms since their cancer diagnosis at their phone
interview. The following items from the Brief Symptom
Inventory [25] were used to measure depressive symp-
toms: since your cancer diagnosis, has there been a period
of at least two straight weeks in which most of the time
you (a) were down, depressed or hopeless, (b) experienced
very little interest or pleasure in doing things, (c) difficulty
sleeping and eating (that was not a result of any medical
treatment)?, felt no energy, difficulty concentrating, feel-
ings of worthlessness and (d) were you told by a medical
doctor or mental health professional that you were de-
pressed. Response options were yes (=1) or no (=0); the
items were summed to yield a symptom score ranging
from 0 to 5. [Cronbach’s α=0.800; 36% no depressive
symptoms; M=1.76; Std Dev=1.74; Skewness=0.54].
Three of the 4-item Perceived Stress Scale [26,27] were
used to measure patients’ perceptions of stress during the
2–3 months following diagnosis and in the month prior
to the phone interview. The excluded PSS item, how often
have you felt ‘that things were going your way?’, was not
asked because it was not specific to challenges and re-
sponse to cancer care. The three included items were
summed and scores ranged from 0 to 12. For stress
recalled for the last month before interview, the
psychometric properties were: Cronbach’s α=0.645;
20.7% no stress; M=3.20; Std Dev=2.62; Skew-
ness=0.59. The psychometric properties for PSS for this
latter time frame were: Cronbach’s α=0.663; 12.5% no
stress; M=4.68; Std Dev=3.02; Skewness=0.19.
The 12-item Functional Assessment of Chronic Illness
Therapy-Spiritual Well-being Scale (FACIT-SP) [28] was
used to measure the spiritual well-being in people with
cancer. Women were asked to indicate ‘how well each
of 12 statements described how you’ve been feeling over
the past seven days’: Response options were not at all
(=0), a little bit, somewhat and a lot (=3). Summed scores
ranged from 4 to 36; M=31.67, Std Dev=5.00, and skew-
ness of 1.58. Factor analyses indicated one factor:
Cronbach’s α=0.820.
The 27-item Functional Assessment of Cancer Therapy
—General cancer questionnaire [29] (FACT—G) was
used to measure physical functioning, social/family func-
tioning, emotional functioning and work/life functional
status. We used the FACT-G because women with a range
of cancers were included in this study and the items cov-
ered were generalizable across all cancer sites. The same
response options used with the FACIT-Sp were used for
FACT-G. Total FACT-G scores ranged from 10 to 81
(M=65.60; Std Dev=12.57; Skewness=1.19, The 27
items scale has good internal consistency (Cronbach’s
α=0.908). FACT-G was designed and used to measure
four subscales of physical wellbeing items (Cronbach’s
α=0.819, Range 0–21, M=15.28; SD=4.86, Skewness
0.866), social/family well-being (Cronbach’s α=0.756,
Range 2–21, M=18.69, SD 3.18, Skewness=2.08),
emotional well-being (Cronbach’s α=0.752, Range
0–18, M=13.97; SD 3.60, Skewness=0.91) and func-
tional well-being (Cronbach’s α=0.805, Range 0–21,
M=17.65, SD=3.93, Skewness=1.57).
Statistical analysis
Internal consistency for the abbreviated measures was cal-
culated using Cronbach’s α. Factor analysis with varimax
rotation was used to determine thematic PIB-C subscales.
Eigenvalues and scree plots determined the optimal number
of factors and the associated variance explained (Table 1).
Correlates of PIB-C: Demographic attributes, PSB-C
and IPV potentially associated with PIB-C (any item ver-
sus no item endorsed) were assessed using either t-tests for
continuous variables or chi-square tests for categorical
variables (Table 2). These bivariate relationships were
used to help identify potential covariates to be included
in multivariable analyses (Tables 3 and 4).
Correlates of distress and QOL outcomes: These same
demographic factors, lifetime IPV and PSB-C scale scores
were investigated as correlates (as independent variables)
of the distress and QOL outcomes (continuous dependent
variables) using analyses of variance.
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Decisionmaking regardingmodel covariates: Variables as-
sociated with both PIB-C and distress or QOL outcomes were
operationally defined as confounders and included in subse-
quent multiple variable modeling. Factors associated with
both PIB-C and either distress or QOL outcomes were in-
cluded in final models as confounders. Because differences
in cancer treatment received may explain associations be-
tween PIB-C and distress or QOL outcomes additional sensi-
tivity analyses were conducted such that cancer treatment was
included in final models. Only cases from the Kentucky Can-
cer Registry were included in this subanalysis because cancer
treatment data was available for only these cases (n=1810).
PIB-C and outcomes: The two specific sets of distress
(perceived stress measured for two time periods and
depressive symptoms (3 items)) and QOL outcomes
(FACIT-Sp and total FACT-G and by four subscales)
were correlated with PIB-C as the primary independent
variable. Because these two sets of outcomes were corre-
lated within sets and negatively correlated with each other,
the associations with PIB-C were conducted using Multi-
variate Analysis of Co-Variance (MANCOVA) where
covariates were defined as variables associated with
PIB-C and the distress or QOL outcomes. Two sets of
MANCOVA analyses were conducted with the distress
Table 3. Proportion of cancer patients experiencing partner interfering behaviors in cancer care (PIB-C) and symptoms of stress,
depression, FACIT-spirituality (Sp) and FACT-general scores and subscales (MANCOVA)
Categorical PIB-C mean score (std error)* p value comparison
No PIB-C ANY PIB-C Higher PIB-C Lower PIB-C
Outcomes (N = 2385) N = 2036 N = 349 N = 176 N = 176
Distress outcomes
Perceived Stress Scale: symptoms1
- 2–3 months after cancer diagnosis 4.57 (0.11) 5.54 (0.18) a 5.71 (0.25)b 5.38 (0.23) c
- In month before study interview 3.28 (0.09) 4.38 (0.15) a 4.64 (0.21) b 4.14 (0.20) c
Depressive symptoms since cancer diagnosis 2 1.76 (0.06) 2.44 (0.10)a 2.62 (0.13) bd 2.28 (0.13) c
QOL outcomes
FACIT-SP Scale3 30.99 (0.18) 28.72 (0.29) a 28.16 (0.41) bd 29.23 (0.38) c
FACT-G Scale4 62.75 (0.41) 56.19 (0.66) a 54.40 (0.90) bd 57.80 (0.86) c
Subscales5 Physical 13.26 (0.16) 11.84 (0.26) a 11.26 (0.36) bd 12.36 (0.34) c
Subscales5 Functional Status 17.12 (0.14) 15.60 (0.22) a 15.49 (0.30)b 15.70 (0.29) c
Subscales5 Emotional 13.79 (0.13) 12.31 (0.21) a 12.00 (0.28) b 12.58 (0.27)c
Subscales5 Social 18.58 (0.10) 16.45 (0.17)a 15.66 (0.23) bd 17.16 (0.22)c
Additionally adjusting for treatment received**
No PIB-C ANY PIB-C Higher PIB-C Lower PIB-C
Outcomes (N = 1810) N = 1551 N = 259 N = 131 N = 128
Distress outcomes
Perceived Stress Scale: symptoms1
- 2–3 months after cancer diagnosis 4.82 (0.11) 5.64 (0.20) a 5.81 (0.28)b 5.49 (0.26) c
- In month before study interview 3.35 (0.09) 4.34 (0.17) a 4.65 (0.24) b 4.07 (0.22) c
Depressive symptoms since cancer diagnosis 2 1.91 (0.06) 2.65 (0.11)a 2.86 (0.16) b 2.47 (0.15) c
QOL outcomes
FACIT-SP Scale3 31.22 (0.18) 29.02 (0.33) a 28.36 (0.45) bd 29.62 (0.43) c
FACT-G Scale4 64.67 (0.41) 58.11 (0.74) a 55.66 (1.03) bd 60.30 (0.98) c
Subscales5 Physical 14.84 (0.16) 13.33 (0.30) a 12.65 (0.41) bd 13.94 (0.39) c
Subscales5 Functional Status 17.44 (0.13) 15.83 (0.24) a 15.56 (0.34)b 16.08 (0.32) c
Subscales5 Emotional 13.63 (0.13) 12.34 (0.23) a 11.89 (0.32) bd 12.73 (0.31)c
Subscales5 Social 18.76 (0.11) 16.61 (0.19)a 15.55 (0.27) bd 17.56 (0.25)c
*Adjusting for age at diagnosis, monthly family income, current smoking status, state of residence, cancer site (breast versus other cancer site), lifetime IPV, PSB score, stage and
number of comorbid conditions.
**Additionally adjusting for treatment received (chemotherapy (yes v no), radiation (yes v no) and other non-surgical treatment (yes v no); 96% received surgery). Treatment data
only available from Kentucky Cancer Registry.
aComparison of Any versus No PIB-C significant at p< .001.
bComparison of Higher versus No PIB-C significant at p< .001.
cComparison of Lower versus No PIB-C significant at p< .001.
dComparison of Higher versus Lower PIB-C significant at p< .05.
1= Perceived Stress Scale [26,27]: 3 items measured patients’ perceptions of their stress during the 2–3 months following cancer diagnosis and 3 items in the month prior to the
phone interview.
2= Depression symptoms: 5 items from the Brief Symptom Inventory [25].
3= FACIT-SP Functional Assessment of Chronic Illness Therapy-Spiritual Well-being Scale. First 12 items. Response options range from not at all (=0) to very much (=4). Recall
frame was past 7 days.
4=Functional Assessment of Cancer Therapy – General questionnaire.
5= FACT-G Subscales measured physical functioning (7 items), social/family functioning (7 items), emotional functioning (6 items) and functional status (7 items).
1210 A. L. Coker et al.
© 2016 The Authors. Psycho-Oncology Published by John Wiley & Sons Ltd. Psycho-Oncology 26: 1205–1214 (2017)
DOI: 10.1002/pon
outcomes included in one model and the QOL outcomes
in the second MANCOVA model.
PIB-C scores were analyzed as both continuous (overall
and by subscale) and categorical (dichotomous and ordinal)
variables. Investigation of categorical variables allows for a
comparison based on exposure to partner behaviors; adjusted
groupmean differences in outcomes scores were presented by
PIB-C exposure, higher (PIB-C ≥2) and lower (PIB-C=1)
versus no PIB-C (Table 3). Exposure to behaviors may be
more useful to healthcare providers as an indicator of impact
to cancer patient’s distress or QOL. Additionally, regression
estimates for PIB-C scores (overall and by the three sub-
scales) as a continuous variable indicate how changes in part-
ner impact distress and QOL outcomes (Table 4).
All analyses in Tables 3 and 4 were adjusted for poten-
tial confounders; sensitivity analyses were conducted with
additional adjustment for cancer treatment received among
cases recruited from the Kentucky Cancer Registry. All
data were analyzed using Statistical Analysis System,
SAS, versions 9.3/4 (SAS Institute; Cary North Carolina).
Results
Response rates
From November 2009 to January 2015, the two cancer
state cancer registries identified 14 224 eligible (age
18–79) women with an incident and primary cancer. Of
these, 3335 completed a phone interview (23.4% response
rate). Interview response rates, defined as completing a
phone interview, did not differ by registry (KCR: 22.9%
(2434/10 623) and NCCR: 25.0% (901/3601)). Within
Table 4. Partner interfering behaviors in cancer care (PIB-C) total score and subscale and symptoms of stress, depression, FACIT-SP and
FACT-G total scores and subscales (MANCOVA)
PIB-C continuous score and three subscales: β estimate (SE)* p value
Outcomes (N = 2385)
PIB-C total
(14 items)
Partner focused on self
(7 items)
Partner cautious
(3 items)
Partner interfered
(4 items)
Distress outcomes
Perceived Stress Scale: symptoms1
- 2–3 months after cancer diagnosis 0.27 (0.05) <.0001 0.38 (0.07) <.0001 0.51 (0.17) .003 0.47 (0.24) .05
- In month before study interview 0.29 (0.04)<.0001 0.36 (0.06) <.0001 0.78 (0.14) <.0001 0.75 (0.20) .0002
Depressive symptoms since cancer diagnosis2 0.18 (0.03) <.0001 0.25 (0.04) <.0001 0.38 (0.09) <.0001 0.38 (0.13) .004
QOL outcomes
FACIT-SP Scale3 0.56 (0.08)<.0001 0.80 (0.12) <.0001 0.88 (0.28) .001 1.26 (0.39) .002
FACT-G Scale4 1.74 (0.19) <.0001 2.56 (0.26) <.0001 2.60 (0.62) <.0001 3.59 (0.89) <.0001
Subscales5 Physical 0.40 (0.07) <.0001 0.57 (0.10) <.0001 0.59 (0.25) .02 0.93 (0.35) .008
Subscales5 Functional Status 0.37 (0.06) <.0001 0.55 (0.09) <.0001 0.43 (0.21).04 0.80 (0.29) .006
Subscales5 Emotional 0.39 (0.06) <.0001 0.54 (0.08) <.0001 0.81 (0.19)<.0001 0.79 (0.28) .004
Subscales5 Social 0.59 (0.05) <.0001 0.89 (0.07) <.0001 0.77 (0.16)<.0001 1.06 (0.23) <.0001
Additionally adjusting for treatment
received** outcomes (N = 1810)
PIB-C Total
(14 items)
Partner focused on self
(7 items)
Partner Cautious
(3 items)
Partner Interfered
(4 items)
Distress outcomes
Perceived Stress Scale: symptoms1
- 2–3 months after cancer diagnosis 0.25 (0.06)<.0001 0.37 (0.08) <.0001 0.44 (0.19).02 0.48 (0.25) .06
- In month before study interview 0.28 (0.05) <.0001 0.32 (0.07) <.0001 0.85 (0.16) <.0001 0.74 (0.21) .0006
Depressive symptoms since cancer diagnosis 2 0.19 (0.03) <.0001 0.25 (0.04) <.0001 0.42 (0.11) .0001 0.38 (0.14) .007
QOL outcomes
FACIT-SP Scale3 0.53 (0.09) <.0001 0.74 (0.13) <.0001 1.03 (0.31) .001 1.06 (0.41) .01
FACT-G Scale4 1.79 (0.21) <.0001 2.62 (0.29) <.0001 2.82 (0.72) .0001 3.72 (0.95) <.0001
Subscales5 Physical 0.41 (0.09) <.0001 0.63 (0.12) <.0001 0.47 (0.29) NS 0.95 (0.38) .01
Subscales5 Functional Status 0.38 (0.07) <.0001 0.56 (0.10) <.0001 0.61 (0.24) .009 0.76 (0.31) .01
Subscales5 Emotional 0.39 (0.07) <.0001 0.53 (0.09) <.0001 0.86 (0.22) .0001 0.86 (0.30) .004
Subscales5 Social 0.60 (0.05) <.0001 0.90 (0.08) <.0001 0.88 (0.19) <.0001 1.14 (0.25) <.0001
*Adjusting for age at diagnosis, monthly family income, current smoking status, state of residence, cancer site (breast versus other cancer site), lifetime IPV, PSB score, stage and
number of comorbid conditions.
**Additionally adjusting for treatment received (chemotherapy (yes v no), radiation (yes v no) and other non-surgical treatment (yes v no); 96% received surgery). Treatment data
only available from Kentucky Cancer Registry.
1= Perceived Stress Scale [26,27]: 3 items measured patients’ perceptions of their stress during the 2–3 months following cancer diagnosis and 3 items in the month prior to the
phone interview.
2= Depression symptoms: 5 items from the Brief Symptom Inventory [25].
3= FACIT-SP Functional Assessment of Chronic Illness Therapy-Spiritual Well-being Scale. Twelve items. Response options range from not at all (=0) to very much (=4). Recall frame
was past 7 days.
4=Functional Assessment of Cancer Therapy—General questionnaire.
5= FACT-G Subscales measured physical functioning (7 items), social/family functioning (7 items), emotional functioning (6 items) and functional status (7 items).
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each state registry, other disposition rates differed some-
what and may be attributable to differences in how
frequently researchers were allowed case contact;
researchers were allowed one contact for NCCR cases
and two with KCR. The physician refusal rate was 3.1%
(KCR: 3.5% (372/10623) and NCCR: 1.9% (69/3601),
and the case refusal rates was 13.9% (KCR: 16.0%
(1700/10 623) and NCCR: 7.6% (275/3601)). The major-
ity 59.6% of women cases could not be contacted by
phone or mail (KCR: 57.6% (6117/10 623) and NCCR:
65.4% (2356/3601).
Given limited access to demographic data on individ-
uals included in the registries yet not consenting to study
participation, we could not determine the
sociodemographic characteristics of those not consenting.
We were able to determine how those not participating
differed from those completing a phone interview based
on whether women lived in an Appalachian region or
not (χ2 =2.54p=NS) and by cancer site. Women diagnosed
with breast cancer were more likely to participate than
women diagnosed with other cancers (χ2 = 10.65 p=.001).
Among the 3335 women completing a phone interview,
931 women were not in an intimate relationship at cancer
diagnosis (27.9%) and were excluded because PIB-C
items were not asked of those without a partner. Also
excluded were women missing demographic factors
(n=10) or violence experienced (n=9). The distribution
of cancer sites among the 2385 women included in this
analyses was: breast cancer (n=1443; 60.7%), female
urogenital (n=296; 12.5%) colorectal (n=164; 6.9%),
head, neck, lung (n=135; 5.7%), hemopoetic (n=102;
4.3%), thyroid (n=107; 4.5%), malignant melanoma
(n=70; 2.9%) and other (n=59; 2.5%). Of the 2385
women in a relationship at cancer diagnosis, 14.7%
endorsed one or more PIB-C item (see Table 1).
Table 2 presents the unadjusted associations between
endorsing at least one PIB-C item and demographic attri-
butes, lifetime and current IPV experienced, and cancer
stage and number of comorbid physical conditions at diag-
nosis. Relative to women endorsing no PIB-C, those
reporting at least one PIB-C were younger, had lower
PSB-C scores indicating less supportive partners, had less
income, less education, were less likely to be currently
married, more likely to be a current smoker, more likely
to be diagnosed at a later cancer stage and had more
comorbid physical conditions. Because PIB-C was
designed to measure psychologically interfering behaviors
influencing cancer care, we anticipated and observed that
women endorsing any PIB-C item were more likely to dis-
close all forms of current and lifetime IPV but particularly
psychological IPV.
Associations with each of the demographic attributes
presented in Table 2 were repeated for the five outcomes
to determine potential confounding factors. Briefly,
increasing age, PSB-C scores, income, education and
current smoking status were inversely correlated with
increasing symptoms of stress and depression and
positively correlated with increasing FACT-G and
FACIT-SP (p< .001). Lifetime IPV, increasing cancer
stage at diagnosis, and increasing number of comorbid
physical conditions were positively correlated with symp-
toms of stress and depression and inversely correlated
with FACT-G and FACIT-SP scores. Based on assess-
ment of potential confounders and (a) PIB-C and (b)
outcomes, the final multiple variable models included
age (in years), stage (0–4), income (1–6 levels), PSB-C
scores (0–5), lifetime IPV (yes v no), current smoking sta-
tus (yes v no), number of comorbid conditions (0–5),
breast cancer (yes v no) and state of cancer registry
(NCCR v KCR). The first seven variables were associated
with both PIB-C and the outcomes; breast cancer site and
state were included as covariates because these were attri-
butes of the study design. Because income, education and
current marital status were highly correlated, only income
was retained in multivariable models as only income
remained significantly associated with the outcomes when
education and marital status were included.
The MANCOVA test for model appropriateness includ-
ing the five correlated outcomes, FACIT-SP and four
FACT_G subscales, and any PIB-C was statistically
significant (Wilks’s Lambda: F (6, 2367) =24.40;
p< .0001). Wilks’ Lambda for the MANCOVA including
the three distress outcomes was also significant
(p< .0001) and indicated appropriateness of model use.
Endorsing any relative to no PIB-C item was associated
with more symptoms of stress in the 2–3 months after can-
cer diagnosis and in the month before interview, more
depressive symptoms since cancer diagnosis and with
significantly lower FACIT-Sp and all 4 FACT-G
subscale scores which indicated poorer QOL. Evidence
of a dose–response pattern of increasing PIB-C items
endorsed and greater depressive symptoms and lower
FACIT-SP and FACT-G physical and social subscales
was observed such that significant differences in these
outcomes were associated with two or more PIB-C
endorsed relative to only one PIB-C and no PIB-C
endorsed. The same patterns were observed for the sensi-
tivity analyses in which cancer treatment was included as
a covariate and analyzed only among Kentucky cases
which suggests that differences in cancer treatment
received do not explain the pattern of PIB-C being asso-
ciated with distress and lower QOL.
The analyses presented in Table 4 provided an indica-
tion of how PIB-C dose, measured as increasing number
of partner interfering behaviors, affects distress and
QOL. Increasing PIB-C scores were associated with
increasing symptoms of stress at both time intervals mea-
sured and with increased numbers of depressive symp-
toms since cancer diagnosis (p< .0001). Additionally,
increasing PIB-C scores were associated with significantly
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lower FACIT-SP and all 4 FACT-G subscales indicating
poorer cancer QOL. These same patterns held for all three
PIB-C subscales with the 7 item PIB-C of ‘Partner focused
on self, not patient’ subscale being the more important
subscale (even with the scales given equal weights for
number of items and included in the same model). Sensi-
tivity analyses which included cancer treatment as a
covariate in MANCOVA models yielded similar findings.
Discussion
As hypothesized, higher PIB-C scores (and each sub-
scales) were associated with (a) reporting more symptoms
of depression or stress, and (b) having lower cancer-
related quality of life as measured with the Functional
Assessment of Cancer Therapy (FACT-G) and Functional
Assessment of Chronic Illness Therapy-Spiritual
Well-being (FACIT-SP) scales even when additionally
controlling for partner support, lifetime IPV, demographic
attributes, cancer site, stage and comorbid conditions.
This large cohort of women recently diagnosed with
cancer from two state registries represents the first to esti-
mate the frequency of partner interfering behaviors and
their impact on a range of cancer outcomes. Our use of
the same interview protocol for all participants in both
cancer registries and use of outcomes measures with
strong psychometric properties limits measurement bias.
This new PIB-C measure had strong internal consistency
and good face and construct validity [18]. Confounding
bias was unlikely to explain these findings because a wide
range of individual and relationship factors were evalu-
ated. Our inclusion of all who met the eligibility criteria
(age, female and included in the cancer registries as an in-
cident and primary cancer in the prior year) improved the
study power and representativeness of our sample. All
communications with potential participants described the
project as the ‘Life stresses, family and partner support
and cancer care for women’ study to indicate the focus
but not exclude those in potentially challenging relation-
ships. Those completing the phone interview may still dif-
fer from those who did not on attributes we can and cannot
measure (e.g. partner violence or other partner behaviors).
We did not find differences in interview completion by
State or region yet breast cancer cases were somewhat
more likely to complete an interview than those with other
cancers. The more likely scenario impacting selection bias
may be that a larger proportion of women currently
experiencing partner interfering behaviors or IPV are
either too ill to be interviewed, refused or could not be
contacted (by phone or mail) than women without these
experiences. If women with these partner experiences
were disproportionately not included AND these women
not participating have poorer cancer outcomes, then our
resulting measures of association would be biased toward
the null; we would have included fewer experiencing
partner interference and poorer cancer outcomes. The
cross-sectional nature of data collection is a study limita-
tion. Women were asked to recall partner behaviors poten-
tially impacting cancer in the past 12 months (after cancer
diagnosis). This retrospective approach was used because
these behaviors could only be measured after cancer diag-
nosis and during treatment or recovery. Using a prospec-
tive assessment of partner behaviors potentially affecting
cancer care just after diagnosis, in the first 3 to 6 months
following diagnosis and up to 12 months following diag-
nosis, would provide a more robust PIB-C measure yet
would be more burdensome for respondents. From these
cross-sectional data we cannot determine directionality
of increasing partner interfering behaviors and greater
symptoms of stress and depression and lower FACT-G
and FACIT-SP scores indicating poorer QOL. These two
sets of outcomes may increase partner interfering behav-
iors. Alternatively, that those who experienced more
symptoms of stress or depression may be more likely to
report negative partner behaviors.
The significance of this study within the body of research
investigating the impact of supportive/unsupportive part-
ner behaviors on health, and specifically oncology out-
comes lies in its identification of partner actions specific
to cancer care or recovery. These interfering partner
behaviors are more serious in nature than ‘unsupportive’
actions yet do not meet the threshold of ‘violence’ which
could be identified in recommended clinical partner vio-
lence screening [30]. Prior measures of unsupportive
behavior typically have addressed general traits of criti-
cism or withdrawal that may not be related to the patient’s
experience of cancer, whereas the PIB-C addresses behav-
iors with considerable consequences for cancer treatment
or QOL (e.g. interfering with sleep, not picking up pre-
scriptions). Where resources must be targeted, screening
using the PIB-C is likely to identify patients more at risk
for poorer outcomes and also to identify areas where inter-
vention might be directed, for example, to services for
transportation, in-home help or support persons. Although
this measure currently requires passage of time from a pa-
tient’s diagnosis for that person to be able to report on their
partner’s actions, future research could identify partner’s
pre-existing traits or abusive behaviors or that are highly
associated with PIB-C. Clinicians could then use this infor-
mation to appropriately screen and identify those relation-
ships in need of targeted counseling and follow up.
In conclusion, these data suggest that patterns of part-
ners’ interfering behaviors are correlated with increased
symptoms of distress and poorer cancer-related QOL.
Others have argued for incorporating IPV screening
within oncology care [31]. Our findings suggest that spe-
cific partner interfering behaviors are more common
(14.7%) than current IPV (10.7%) and have similar cancer
impact [1]. Additional evidence-based research is needed
to determine the role of patient screening for problematic
1213Impact of partner interfering behaviors on women’s cancer care and recovery
© 2016 The Authors. Psycho-Oncology Published by John Wiley & Sons Ltd. Psycho-Oncology 26: 1205–1214 (2017)
DOI: 10.1002/pon
partner behaviors (including abuse) in preventing the
potentially dramatic impact of these behaviors on
women’s cancer care and recovery. The recent Affordable
Care Act requirement and ACOG endorsement of domes-
tic violence screening as part of routine care for reproduc-
tive aged women is an example of a policy intervention
that may be relevant for improving cancer care in
oncologic settings [30,31].
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